B. Metzler seel. Sohn & Co. AG Boosts Holdings in Humana Inc. $HUM

Key Points

• B. Metzler seel. Sohn & Co. AG increased its Humana stake by 51.8% in the second quarter, bringing its holdings to 8,029 shares valued at approximately $3.19 million. Institutional investors collectively own 92.38% of Humana.
• Analysts remain mixed, with Humana receiving an overall “Hold” consensus rating and an average price target of $403.91; the stock recently opened at $400.70.
• Humana exceeded quarterly earnings expectations, reporting $7.61 EPS and $40.89 billion in revenue, while revenue grew 26.2% year over year. The company also declared a quarterly dividend of $0.885 per share, representing a 0.9% annualized yield.

B. Metzler seel. Sohn & Co. AG grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 51.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,029 shares of the insurance provider's stock after purchasing an additional 2,741 shares during the period. B. Metzler seel. Sohn & Co. AG's holdings in Humana were worth $3,189,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Johnson Financial Group Inc. bought a new position in shares of Humana during the second quarter valued at approximately $26,000. Trust Co. of Vermont purchased a new stake in shares of Humana in the second quarter worth $28,000. Bogart Wealth LLC increased its holdings in shares of Humana by 192.0% during the second quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. MidFirst Bank bought a new position in Humana in the 2nd quarter worth about $35,000. Finally, Fideuram Asset Management Ireland dac purchased a new stake in Humana during the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Robert W. Baird set a $390.00 price target on Humana in a report on Thursday, July 30th. JPMorgan Chase & Co. raised their price target on shares of Humana from $316.00 to $393.00 and gave the company a "neutral" rating in a report on Monday, August 10th. Weiss Ratings upgraded shares of Humana from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, August 14th. Morgan Stanley upgraded shares of Humana from an "underweight" rating to an "equal weight" rating and increased their price objective for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Finally, HSBC downgraded shares of Humana to a "hold" rating in a research report on Thursday, July 30th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $403.91.

Humana Stock Down 1.4%

Shares of NYSE HUM opened at $400.70 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The stock has a 50 day moving average price of $388.44 and a 200 day moving average price of $296.00. The firm has a market capitalization of $48.12 billion, a price-to-earnings ratio of 37.91, a PEG ratio of 2.67 and a beta of 0.74. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period last year, the firm earned $6.27 earnings per share. Humana's revenue was up 26.2% compared to the same quarter last year. Sell-side analysts expect that Humana Inc. will post 9 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana's payout ratio is 33.49%.

Humana Company Profile

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source